selegiline has been researched along with Tremor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correa, M; Dortche, K; Podurgiel, SJ; Salamone, JD; Yohn, SE | 1 |
| Aasly, JO; Beiske, AG; Bekkelund, SI; Dietrichs, E; Larsen, JP; Tysnes, OB; Vilming, ST | 1 |
| Holford, NH; Nutt, JG; Vu, TC | 1 |
| Kang, SY; Lee, MH; Lee, SK; Sohn, YH | 1 |
| Bhat, V; Weiner, WJ | 1 |
| Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
| Bhatia, M; Jain, S; Maheshwari, MC | 1 |
| Bowes, SG; Charlett, A; Dickins, J; Dobbs, RJ; Dobbs, SM; Faulkner, G; Hunt, WB; Kirollos, C; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C | 1 |
| Agnoli, A; Carta, A; Denaro, A; Meco, G; Ruggieri, S; Stocchi, F | 1 |
2 review(s) available for selegiline and Tremor
| Article | Year |
|---|---|
[Motor symptoms in Parkinson disease].
Topics: Age Factors; Antiparkinson Agents; Deep Brain Stimulation; Dopamine Agonists; Dyskinesias; Dystonia; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Selegiline; Treatment Outcome; Tremor | 2008 |
Parkinson's disease. Diagnosis and the initiation of therapy.
Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor | 2005 |
2 trial(s) available for selegiline and Tremor
| Article | Year |
|---|---|
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonism.
Topics: Aged; Antiparkinson Agents; Arousal; Double-Blind Method; Female; Gait; Humans; Hypokinesia; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Research Design; Selegiline; Treatment Outcome; Tremor | 1996 |
Multicenter trial of L-Deprenyl in Parkinson disease.
Topics: Adult; Affect; Aged; Clinical Trials as Topic; Disability Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline; Tremor | 1986 |
5 other study(ies) available for selegiline and Tremor
| Article | Year |
|---|---|
The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Jaw; Male; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Random Allocation; Rats, Sprague-Dawley; Selegiline; Tetrabenazine; Tremor; Vesicular Monoamine Transport Proteins | 2016 |
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Topics: Antiparkinson Agents; Cognition Disorders; Depression; Disability Evaluation; Disease Progression; Drug Substitution; Drug Therapy, Combination; Gait Disorders, Neurologic; Humans; Hypokinesia; Linear Models; Motor Activity; Nonlinear Dynamics; Parkinson Disease; Patient Dropouts; Postural Balance; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selegiline; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Tocopherols; Treatment Outcome; Tremor | 2012 |
Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum.
Topics: Adolescent; Antiparkinson Agents; Benztropine; Cognition Disorders; Corpus Callosum; Electroencephalography; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Weakness; Neuropsychological Tests; Parkinson Disease; Selegiline; Spastic Paraplegia, Hereditary; Tremor | 2004 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Role of selegiline as initial monotherapy in early Parkinson's disease.
Topics: Activities of Daily Living; Drug Tolerance; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Safety; Selegiline; Time Factors; Tremor | 1994 |